MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Detection of Levodopa induced Dyskinesia based on spectral features from subthalamic-LFP and sensorimotor-ECoG

    J. Habets, R. Lofredi, J. Busch, V. Mathiopoulou, J. Roediger, R. Koehler, J. Vanhoecke, P. Krause, K. Faust, GH. Schneider, WJ. Neumann, A. Kühn (Berlin, Germany)

    Objective: To detect the presence of Levodopa induced Dyskinesia (LID) in Parkinson’s disease (PD) patients based on spectral characteristics from invasive cortico-subthalamic recordings using machine…
  • 2023 International Congress

    Comparative efficacy of pharmacological cognitive treatments in Parkinson’s disease and Dementia of Lewy Bodies: systemic review & network meta-analysis

    F. Al Hajraf, S. Manohar, M. Hu (Oxford, United Kingdom)

    Objective: The aim of this study is to evaluate, compare and rank the currently available pharmacological cognitive treatments. Background: Treating cognitive impairment in Parkinson’s disease…
  • 2023 International Congress

    Dopamine dysfunction in nigro-striatal pathway—multi-axial pathology in SCA 12

    P. Basu, J. Ganguly, S. Pandey, S. Mukherjee, N. Singh, S. Choudhury, H. Kumar (Kolkata, India)

    Objective: To assert pathophysiology in spinocerebellar ataxia type 12 (SCA12) extends way beyond cerebellar or spinal pathology. To further sensitise scientific community about consistent nigro-striatal…
  • 2023 International Congress

    Exploring patient-physician communication in Parkinson’s disease management: a qualitative analysis

    A. Pilotto, L. Tonges, J. Pagonabarraga (Brescia, Italy)

    Objective: To explore the unmet needs in patient-physician communication from different perspective.To explore the unmet needs in patient-physician communication from different perspective. Background: Patient-physician communication…
  • 2023 International Congress

    Data-driven Clustering of Neurodegenerative diseases based on EEG Spectrum power-law decay: the DaCNES Study.

    G. Mostile, R. Terranova, G. Carlentini, C. Terravecchia, G. Donzuso, G. Sciacca, C. Cicero, A. Luca, A. Nicoletti, M. Zappia (Catania, Italy)

    Objective: To test accuracy of the power law exponent β applied to EEG in differentiating neurodegenerative diseases and to explore differences in neuronal connectivity among…
  • 2023 International Congress

    PASADENA 1-year open-label extension

    G. Pagano, A. Reyes, A. Monnet, M. Martinec, N. Shariati, T. Simuni, K. Marek, R. Postuma, N. Pavese, F. Stocchi, K. Taylor, H. Svoboda, P. Fontoura, G. Kerchner, R. Doody, A. Bonni, T. Nikolcheva (Basel, Switzerland)

    Objective: To describe the results of PASADENA 1-year open-label extension (OLE). Background: Prasinezumab is a humanized monoclonal antibody that binds aggregated alpha-synuclein with the potential…
  • 2023 International Congress

    An analysis of gender differences in the clinical profile of Parkinson’s Disease patients

    M. Nasi, N. Cazzola, L. Weis, E. Fiorenzato, V. Cianci, F. Pistonesi, A. Antonini, R. Biundo (Padova, Italy)

    Objective: The present study aimed at characterising in depth the overall clinical profile of male and females PD patients. Background: Parkinson Disease (PD) is the…
  • 2023 International Congress

    Cholinergic deficits in Parkinson Disease

    R. Miller, D. Dhavale, J. O’Shea, E. Franklin, N. Cairns, R. Perrin, M. Campbell, J. Perlmutter, P. Kotzbauer (St. Louis, USA)

    Objective: To determine whether loss of cholinergic projections to cortical and limbic regions contributes to the development of dementia in Parkinson’s disease (PD). Background: PD…
  • 2023 International Congress

    Stability of beta oscillations during aDBS in Parkinson’s disease: a methodology for reliable assessment

    S. Marceglia, A. Caruso, M. Prenassi, M. Arlotti, T. Bocci, L. Borellini, S. Pastore (Trieste, Italy)

    Objective: In this work, we describe a methodology to assess whether a specific oscillation, considered as biomarker for adaptive DBS (aDBS), is stabilized during stimulation,…
  • 2023 International Congress

    Generalized acute myoclonus caused by chikungunya virus encephalitis: case report.

    A. Gomes, A. Marinho, F. Rolim, D. Lima, F. Araújo, K. Menezes, V. Mesquita, F. Maia Carvalho (Fortaleza, Brazil)

    Objective: Our goal is to describe a case of generalized acute myoclonus in a patient with Chikungunya virus (CHIKV) encephalitis. Background: There have been an…
  • « Previous Page
  • 1
  • …
  • 42
  • 43
  • 44
  • 45
  • 46
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
        • Help & Support
        • About Us
        • Cookies & Privacy
        • Wiley Job Network
        • Terms & Conditions
        • Advertisers & Agents
        Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
        Wiley